AMD vs MRK: Which Is the Better Buy?
Side-by-side comparison of Advanced Micro Devices, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Advanced Micro Devices, Inc. · Technology
$614.61
-13.7% upside to fair value
Med Conviction
Grade C
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
MRK has more upside to fair value
(-4.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMD |
MRK |
| Current Price |
$614.61 |
$147.17 |
| Fair Value Estimate |
$530.25 |
$141.07 |
| Upside to Fair Value |
-13.7%
|
-4.1%
|
| Market Cap |
$1,002.2B |
$363.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
93.4x
|
29.6x
|
| Price / Sales |
24.3x
|
5.5x
|
| Price / FCF |
119.3x
|
22.6x
|
| Revenue Growth YoY |
+50.1%
|
+5.1%
|
| Gross Margin |
53.2%
|
75.4%
|
| Operating Margin |
15.7%
|
16.7%
|
| Return on Equity |
10.1%
|
6.6%
|
| Dividend Yield |
0% |
2.31% |
| FCF Yield |
0.84%
|
4.42%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
| Metric |
AMD |
MRK |
| Zone Low |
$397.69 |
$105.80 |
| Zone High |
$450.71 |
$119.91 |
| In Buy Zone? |
No
|
No
|